API Manufacturer Flagged for Quality, Investigational Issues

Drug GMP Report
A A
The FDA cited API manufacturer CIL Isotope Separations after an inspection of its Xenia, Ohio facility revealed quality control issues, investigational deficiencies and other violations.

To View This Article:

Login

Subscribe To Drug GMP Report